We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
Cap. Flow
-$270M
Cap. Flow %
-17.18%
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37

Top Buys

Rank Stock Value
1
BZUN
Baozun
BZUN
+$17.1M
2
MOMO
Hello Group
MOMO
+$5.31M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$4.25M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.13M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.26M

Top Sells

Rank Stock Value
1
KANG
iKang Healthcare Group, Inc.
KANG
+$94.3M
2
VIPS icon
Vipshop
VIPS
+$47.3M
3
DBRG icon
DigitalBridge
DBRG
+$39.3M
4
BKD icon
Brookdale Senior Living
BKD
+$37.8M
5
CRTO icon
Criteo S.A. Ordinary Shares
CRTO
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.62%
2 Financials 6.46%
3 Consumer Discretionary 4.13%
4 Industrials 2.9%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEM icon
51
Newmont
NEM
$96.2B
$3.58M 0.23%
100,690
+79,490
+375% +$2.69M
BBU
52
DELISTED
Brookfield Business Partners
BBU
$3.38M 0.21%
+75,610
New +$1.69M
XOMA
53
DELISTED
Xoma
XOMA
$3.35M 0.21%
269,877
-46,357
-15% -$634K
CTSH icon
54
Cognizant
CTSH
$25.2B
$3.31M 0.21%
46,250
– –
STML
55
DELISTED
Stemline Therapeutics, Inc.
STML
$3.29M 0.21%
267,936
+209,936
+362% +$2.37M
BRK.B icon
56
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.17M 0.2%
15,800
-900
-5% -$182K
RARE icon
57
Ultragenyx Pharmaceutical
RARE
$2.46B
$3.15M 0.2%
46,144
+21,144
+85% +$1.21M
ALDR
58
DELISTED
Alder Biopharmaceuticals
ALDR
$3.11M 0.2%
233,858
+49,045
+27% +$635K
CERS icon
59
Cerus
CERS
$575M
$3.09M 0.2%
498,538
– –
MSFT icon
60
Microsoft
MSFT
$2.9T
$3.08M 0.2%
26,325
-22,623
-46% -$2.47M
HARP
61
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$3.06M 0.19%
+32,340
New +$4.25M
ARCC icon
62
Ares Capital
ARCC
$13.4B
$3.06M 0.19%
178,707
+50,000
+39% +$838K
CFRX
63
DELISTED
ContraFect Corporation
CFRX
$2.98M 0.19%
9,317
-3
-0% -$1.3K
DCPH
64
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.97M 0.19%
128,037
– –
GOOG icon
65
Alphabet (Google) Class C
GOOG
$4.11T
$2.83M 0.18%
48,420
+10,000
+26% +$561K
LJPC
66
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.74M 0.17%
416,260
+107,610
+35% +$701K
UNH icon
67
UnitedHealth
UNH
$382B
$2.73M 0.17%
11,270
-20
-0.2% -$5.1K
MYOK
68
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.7M 0.17%
51,967
+25,454
+96% +$1.17M
MDT icon
69
Medtronic
MDT
$112B
$2.68M 0.17%
+29,800
New +$2.67M
DRNA
70
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.67M 0.17%
188,673
+74,735
+66% +$859K
HDB icon
71
HDFC Bank
HDB
$123B
$2.64M 0.17%
93,040
+19,760
+27% +$512K
CHRS icon
72
Coherus Oncology
CHRS
$217M
$2.64M 0.17%
192,248
+126,748
+194% +$1.69M
MO icon
73
Altria Group
MO
$125B
$2.63M 0.17%
46,347
+15,547
+50% +$795K
PTLA
74
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.51M 0.16%
74,800
– –
OBSV
75
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.49M 0.16%
+194,991
New +$2.52M
1 2
3
4 5

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q1 2019 Portfolio in Review

As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Fosun International opened a new position in Baozun worth $20.3M.

  • Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
  • Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
  • Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
  • Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
  • Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
  • Fosun International opened 45 new positions and closed 37 in Q1 2019.
  • Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.